Pharmacoeconomic outcomes of levalbuterol [levosalbutamol] and racemic albuterol [salbutamol] in inpatients requiring nebulization (POLARIS).
Phase of Trial: Phase IV
Latest Information Update: 21 Feb 2012
At a glance
- Drugs Levosalbutamol; Salbutamol
- Indications Acute asthma; Asthma; Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms POLARIS
- Sponsors Sunovion Pharmaceuticals
- 01 Sep 2008 Results were reported in Clinical Therapeutics.
- 19 May 2008 New trial record.